Cationic LIposome capsulated CRISPR-Cas13a Kit (CLICK) for in situ detection of circulating PD-L1 mRNA in single EV towards monitoring of immunotherapy efficacy
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2025.118032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Yingjing Fan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Researc…. Hauptthemen laut MEDLINE: RNA, Messenger, B7-H1 Antigen, Extracellular Vesicles, Biosensing Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Key Technologies Research and Development Program of Guangzhou Municipality, National Key Research and Development Program of China, Southern Medical University.
Abstract (Originalsprache)
Tumor immunotherapy has significantly improved cancer treatment, yet immune checkpoint inhibitors only benefit a subset of patients. A critical challenge is non-invasive detection of tumor PD-L1 mRNA, a key biomarker that dynamically reflects PD-L1 expression and correlates with therapeutic outcomes. Current methods are hindered by the instability of circulating mRNA and the need for invasive tissue biopsies. Herein, we introduce the Cationic LIposome capsulated CRISPR-Cas13a Kit (CLICK) for in-situ detection of circulating PD-L1 mRNA in extracellular vesicles (EVs). CLICK achieves direct target identification in 10 μL plasma within 2 h without EV purification or RNA extraction, demonstrating a detection limit of 103 EV/mL for PD-L1 mRNA. By integrating membrane fusion-mediated CRISPR delivery with nanoflow cytometry, CLICK resolves PD-L1 mRNA (+) EV subpopulations at single-vesicle resolution, revealing heterogeneous distributions. Clinically validated in 53 immunotherapy patients, CLICK accurately stratifies progressive disease (PD) from stable disease (SD) patients (AUC = 0.8236; 95 % CI: 0.7054-0.9417; p = 0.0006) based on PD-L1 mRNA (+) EV percentages. This work establishes a rapid, blood-based paradigm for therapy response monitoring, advancing liquid biopsy through precise EV RNA characterization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Lab…
Förderung
- Key Technologies Research and Development Program of Guangzhou Municipality
- National Key Research and Development Program of China
- Southern Medical University
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Science Fund for Distinguished Young Scholars
Zitieren
APA
Fan, Y., Pan, W., Xiu, Q., Qiao, Y., Zhang, P., Liao, T., Feng, J., Nie, C., Chu, S., Li, N., Wu, X., Zheng, L., Cai, Z., & Li, B. (2026). Cationic LIposome capsulated CRISPR-Cas13a Kit (CLICK) for in situ detection of circulating PD-L1 mRNA in single EV towards monitoring of immunotherapy efficacy. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.118032
Vancouver
Fan Y, Pan W, Xiu Q, Qiao Y, Zhang P, Liao T, et al. Cationic LIposome capsulated CRISPR-Cas13a Kit (CLICK) for in situ detection of circulating PD-L1 mRNA in single EV towards monitoring of immunotherapy efficacy. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2025.118032
BibTeX
@article{Fan2026,
author = {Fan, Yingjing and Pan, Weilun and Xiu, Qi and Qiao, Yue and Zhang, Peng and Liao, Tong and Feng, Junjie and Nie, Chengtao and Chu, Shuai and Li, Ningcen and Wu, Xiuhua and Zheng, Lei and Cai, Zhen and Li, Bo},
title = {Cationic LIposome capsulated CRISPR-Cas13a Kit (CLICK) for in situ detection of circulating PD-L1 mRNA in single EV towards monitoring of immunotherapy efficacy},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2025.118032}
}
EUVIMED